-
There was an increased rate of stroke on patients who received Niaspan, but researchers cautioned that this may be due to chance.
FORBES: HDL-Raising Drug Fails To Show Benefit In Government Study
-
The rate of ischemic stroke increased by 31% in five to 14-year-olds, from 3.2 strokes per 10, 000 hospital cases to 4.2 per 10, 000.
BBC: US stroke rates 'rising in young'
-
After years of controversy, the Food and Drug Administration has asked Abbott Laboratories to yank the weight loss drug Meridia, generically known as sibutramine, from the market as a result of a large clinical trial that found the drug increased the rate of heart attack and stroke in patients at high cardiovascular risk.
FORBES: FDA Yanks Meridia -- And Finds It In A Supplement
-
This week I refinanced my mortgage at a new, better rate, lowering my monthly expenses with a stroke of the pen.
FORBES: Magazine Article
-
But the report found that while aspirin may slow changes in cognitive ability in women at high risk of a heart attack or stroke, it made no difference to the rate at which the women developed dementia - which was also examined for by a neuropsychiatrist.
BBC: Aspirin may 'slow elderly brain decline', study finds
-
While niacin showed no difference from placebo in the death rate of the men in this study, fewer patients on niacin had a non-fatal heart attack or stroke, by 26% and 24%, respectively.
FORBES: Niacin, Statins And Difficulties Of Drug Discovery
-
Many researchers, however, point out that the 30-day stroke and death rate in stent patients was significantly higher (4.8%) than that of surgery patients (2.6%).
WSJ: Are Stroke Drugs Better Than Stents?